CD73-IN-3 是一种有效的选择性 CD73 抑制剂，IC50 为 28 nM，具有癌症的研究潜力。详细信息来源于专利 WO2019168744 A1 中的例 2 。

LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.

2375815-63-5

C15H18N4O2

286.335

EX-A4254;LY-3475070

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years